SCHEDULE 13G

Company

Alaunos Therapeutics, Inc.

Filed

May 11, 2006

Accession Number

0000932440-06-000241

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →